Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study

Abstract Background The optimal route of progesterone administration for luteal support in cryopreserved embryo transfer (CET) has been the subject of much debate. While most published research has pertained to day 3 transfers, recent data on blastocyst CET has suggested that intramuscular progester...

Full description

Bibliographic Details
Main Authors: Jennifer B. Bakkensen, Catherine Racowsky, Ann M. Thomas, Andrea Lanes, Mark D. Hornstein
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Fertility Research and Practice
Subjects:
IVF
Online Access:http://link.springer.com/article/10.1186/s40738-020-00079-y
id doaj-34b5bf739555488d9b9a0d8dc2b6c348
record_format Article
spelling doaj-34b5bf739555488d9b9a0d8dc2b6c3482020-11-25T03:41:16ZengBMCFertility Research and Practice2054-70992020-07-01611610.1186/s40738-020-00079-yIntramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort studyJennifer B. Bakkensen0Catherine Racowsky1Ann M. Thomas2Andrea Lanes3Mark D. Hornstein4Department of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolDepartment of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolDepartment of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolDepartment of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolDepartment of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolAbstract Background The optimal route of progesterone administration for luteal support in cryopreserved embryo transfer (CET) has been the subject of much debate. While most published research has pertained to day 3 transfers, recent data on blastocyst CET has suggested that intramuscular progesterone (IMP) is superior to twice daily vaginal Endometrin suppositories for luteal phase support, resulting in significantly higher ongoing pregnancy rates. This study aimed to determine whether IMP is similarly superior to 8% Crinone vaginal gel for luteal phase support following blastocyst CET. Methods Autologous and donor oocyte blastocyst cryopreserved single embryo transfer (SET) cycles from January 2014–January 2019 utilizing either 50 mg IMP daily or 90 mg 8% Crinone gel twice daily for luteal support were included. The primary outcome was live birth. Secondary outcomes included biochemical pregnancy, spontaneous abortion, and clinical pregnancy. All analyses were adjusted a priori for oocyte age. Log-binomial regression analysis was performed with differences in outcomes reported as relative risk (RR) with 95% confidence intervals (CI). Results A total of 1710 cycles were included, of which 1594 utilized IMP and 116 utilized 8% Crinone gel. Demographic and cycles characteristics were similar between the two groups. Compared to cycles utilizing IMP, cycles utilizing Crinone gel resulted in similar rates of live birth (RR 0.91; 95% CI 0.73–1.13), biochemical pregnancy (RR 1.12, 95% CI 0.65–1.92), spontaneous abortion (RR 1.41, 95% CI 0.90–2.20), and clinical pregnancy (RR 1.00, 95% CI 0.86–1.17). Conclusions Compared to cryopreserved blastocyst SET cycles utilizing IMP for luteal support, cycles utilizing 8% Crinone gel resulted in similar likelihood of live birth.http://link.springer.com/article/10.1186/s40738-020-00079-yLuteal supportIntramuscular progesteroneVaginal progesteroneCrinoneIVFCryo embryo transfer
collection DOAJ
language English
format Article
sources DOAJ
author Jennifer B. Bakkensen
Catherine Racowsky
Ann M. Thomas
Andrea Lanes
Mark D. Hornstein
spellingShingle Jennifer B. Bakkensen
Catherine Racowsky
Ann M. Thomas
Andrea Lanes
Mark D. Hornstein
Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
Fertility Research and Practice
Luteal support
Intramuscular progesterone
Vaginal progesterone
Crinone
IVF
Cryo embryo transfer
author_facet Jennifer B. Bakkensen
Catherine Racowsky
Ann M. Thomas
Andrea Lanes
Mark D. Hornstein
author_sort Jennifer B. Bakkensen
title Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
title_short Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
title_full Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
title_fullStr Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
title_full_unstemmed Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
title_sort intramuscular progesterone versus 8% crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
publisher BMC
series Fertility Research and Practice
issn 2054-7099
publishDate 2020-07-01
description Abstract Background The optimal route of progesterone administration for luteal support in cryopreserved embryo transfer (CET) has been the subject of much debate. While most published research has pertained to day 3 transfers, recent data on blastocyst CET has suggested that intramuscular progesterone (IMP) is superior to twice daily vaginal Endometrin suppositories for luteal phase support, resulting in significantly higher ongoing pregnancy rates. This study aimed to determine whether IMP is similarly superior to 8% Crinone vaginal gel for luteal phase support following blastocyst CET. Methods Autologous and donor oocyte blastocyst cryopreserved single embryo transfer (SET) cycles from January 2014–January 2019 utilizing either 50 mg IMP daily or 90 mg 8% Crinone gel twice daily for luteal support were included. The primary outcome was live birth. Secondary outcomes included biochemical pregnancy, spontaneous abortion, and clinical pregnancy. All analyses were adjusted a priori for oocyte age. Log-binomial regression analysis was performed with differences in outcomes reported as relative risk (RR) with 95% confidence intervals (CI). Results A total of 1710 cycles were included, of which 1594 utilized IMP and 116 utilized 8% Crinone gel. Demographic and cycles characteristics were similar between the two groups. Compared to cycles utilizing IMP, cycles utilizing Crinone gel resulted in similar rates of live birth (RR 0.91; 95% CI 0.73–1.13), biochemical pregnancy (RR 1.12, 95% CI 0.65–1.92), spontaneous abortion (RR 1.41, 95% CI 0.90–2.20), and clinical pregnancy (RR 1.00, 95% CI 0.86–1.17). Conclusions Compared to cryopreserved blastocyst SET cycles utilizing IMP for luteal support, cycles utilizing 8% Crinone gel resulted in similar likelihood of live birth.
topic Luteal support
Intramuscular progesterone
Vaginal progesterone
Crinone
IVF
Cryo embryo transfer
url http://link.springer.com/article/10.1186/s40738-020-00079-y
work_keys_str_mv AT jenniferbbakkensen intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy
AT catherineracowsky intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy
AT annmthomas intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy
AT andrealanes intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy
AT markdhornstein intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy
_version_ 1724530688440401920